Nanostim signs investment deal with St. Jude

Milpitas, CA-based Nanostim has reached an agreement with St. Jude Medical, which has committed to a staged financing of the pacemaker developer, subject to it achieving certain development and clinical milestones. The agreement also gives St. Jude Medical the exclusive option to acquire the company. Nanostim release

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.